SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Gettex System der Börse München
Börse Gettex System der Börse München
Symbol ILU
EUR
  • Illumina, Inc.
    Börse Xetra Frankfurt
    Symbol ILU
    EUR
  • Illumina
    Börse Börse Berlin
    Symbol ILU
    EUR
  • Illumina
    Börse Börse Düsseldorf
    Symbol ILU
    EUR
  • Illumina
    Börse Quotrix System der Börse Düsseldorf
    Symbol ILU
    EUR
  • Illumina
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol ILU
    EUR
  • Illumina
    Börse Gettex System der Börse München
    Symbol ILU
    EUR
  • ILLUMINA INC
    Börse Börse Frankfurt
    Symbol ILU
    EUR
  • ISIN US4523271090 WKN: 927079
    Symbol ILMN
    USD
  • EUR
  • Symbol ILU
  • Symbol ILU
  • MXN
  • BRL
  • USD
Symbol ILU
Währung EUR
Börse Gettex System der Börse München Zeitzone: America/Mexico_City
Firmenname Illumina, Inc
Marktkapitalisierung 49.238.259.659 (+- 16%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

52.746.878.976 oder 56.913.000.000 oder 38.054.900.000

Mitarbeiter 8.750 (+- 12%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

7.700 oder 9.800 Mitarbeiter

Anzahl Aktien 146.000.000
KGV 66.22 (+- 26%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

83.75 oder 48.7

EBITDA 1.007.000.000
PEGRatio 2.3707
Buchwert 32.192

Aktionärsstruktur der Illumina, Inc

146 News & Informationen zur Illumina Aktie

  • Illumina announces acquisition of GRAIL (NASDAQ:ILMN)
    seekingalpha.com

    Illumina announces acquisition of GRAIL (NASDAQ:ILMN)

    Illumina (ILMN) has acquired GRAIL (GRAL), the developer of Galleri blood test that detects 50 different cancers before symptoms appear

  • Premier Asset Management Llc Buys Coupa Software Inc, Hess Corp, Baker Hughes Co, Sells General Electric Co, Fiserv Inc, Qualcomm Inc
    gurufocus.com

    Premier Asset Management Llc Buys Coupa Software Inc, Hess Corp, Baker Hughes Co, Sells General Electric Co, Fiserv Inc, Qualcomm Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Illumina Bumping Against Top of Analysts' Price Estimates
    gurufocus.com

    Illumina Bumping Against Top of Analysts' Price Estimates

    GuruFocus Article or News written by Barry Cohen and the topic is about: Company shares up about 40% in past 3 months

  • Illumina vs. CRISPR: Which Genomics Stock is a Better Choice? By StockNews
    investing.com

    Illumina vs. CRISPR: Which Genomics Stock is a Better Choice? By StockNews

    Illumina vs. CRISPR: Which Genomics Stock is a Better Choice?

  • MARSHALL WACE ASIA Ltd Buys Alphabet Inc, Illumina Inc, Otis Worldwide Corp, Sells Darling Ingredients Inc, Alaska Air Group Inc,...
    gurufocus.com

    MARSHALL WACE ASIA Ltd Buys Alphabet Inc, Illumina Inc, Otis Worldwide Corp, Sells Darling Ingredients Inc, Alaska Air Group Inc, Intercontinental Exchange Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Perennial Advisors, LLC Buys VanEck Vectors Investment Grade Floating Rate ETF, Colgate-Palmolive Co, WisdomTree Emerging Markets ESG Fund,...
    gurufocus.com

    Perennial Advisors, LLC Buys VanEck Vectors Investment Grade Floating Rate ETF, Colgate-Palmolive Co, WisdomTree Emerging Markets ESG Fund, Sells Triton International, iShares Gold Trust, General Elec

    GuruFocus Article or News written by insider and the topic is about:

  • AtonRa Partners Buys Marvell Technology Inc, SolarEdge Technologies Inc, Veeva Systems Inc, Sells Guardant Health Inc, Vertex...
    gurufocus.com

    AtonRa Partners Buys Marvell Technology Inc, SolarEdge Technologies Inc, Veeva Systems Inc, Sells Guardant Health Inc, Vertex Pharmaceuticals Inc, Illumina Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Life Science Tools Markets, 2017-2020 & 2021-2028 - Rise in the Number of Strategic Deals & Developments
    prnewswire.com

    Global Life Science Tools Markets, 2017-2020 & 2021-2028 – Rise in the Number of Strategic Deals & Developments

    /PRNewswire/ — The “Life Science Tools Market Size, Share & Trends Analysis Report by Technology (Cell Biology, Genomics), by Product (Flow Cytometry, Mass…

  • ‘QQQA’ Won’t Miss Its Shot as Pfizer and Moderna Set to Profit with Boosters
    etftrends.com

    ‘QQQA’ Won’t Miss Its Shot as Pfizer and Moderna Set to Profit with Boosters

    Analysts and healthcare investors estimate that Moderna and Pfizer will earn billions from Covid-19 boosters in the coming months…

  • HTG Molecular Diagnostics Reports Second Quarter 2021 Results
    globenewswire.com

    HTG Molecular Diagnostics Reports Second Quarter 2021 Results

    Call scheduled for today, August 12, at 4:30pm ET…

  • Illumina laments EU regulators' pause into Grail deal probe
    financialpost.com

    Illumina laments EU regulators' pause into Grail deal probe

    BRUSSELS — U.S. life sciences company Illumina Inc on Thursday deplored EU antitrust regulators’ decision to suspend temporarily their investigation into its…

  • Illumina : laments EU regulators' pause into Grail deal probe
    marketscreener.com

    Illumina : laments EU regulators' pause into Grail deal probe

    U.S. life sciences company
    Illumina Inc on Thursday deplored EU antitrust
    regulators' decision to suspend temporarily their investigation
    into its planned purchase of Grail Inc, saying that the
    cancer… | August 12, 2021

  • If You Invested $1000 in Illumina 10 Years Ago, This Is How Much You'd Have Now
    zacks.com

    If You Invested $1000 in Illumina 10 Years Ago, This Is How Much You'd Have Now

    Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

  • Infertility Testing and Treatment Market: A rise in infertility and treatment awareness and the introduction of novel testing devices to...
    news.google.com

    Infertility Testing and Treatment Market: A rise in infertility and treatment awareness and the introduction of novel testing devices to drive the market

    Infertility Testing and Treatment Market: A rise in infertility and treatment awareness and the introduction of novel testing devices to drive the market – read this article along with other careers information, tips and advice on BioSpace

  • ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
    globenewswire.com

    ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics

    Nebula Founder and Renowned Harvard Scientist, George Church, Ph.D., to Spearhead ProPhase Labs New Scientific Advisory Board GARDEN CITY, NY, Aug. 11,…

  • Biotechnology Reagents & Kits Market Size Worth $1.14 Trillion By 2028: Grand View Research, Inc.
    markets.businessinsider.com

    Biotechnology Reagents & Kits Market Size Worth $1.14 Trillion By 2028: Grand View Research, Inc.

    SAN FRANCISCO, Aug. 10, 2021 /PRNewswire/ — The global biotechnology reagents & kits market size is expected to reach USD 1.14 trillion by 2028, …

  • Veritas Investment Partners (UK) Ltd. Buys Synopsys Inc, Sells Xylem Inc, Illumina Inc, Ansys Inc
    gurufocus.com

    Veritas Investment Partners (UK) Ltd. Buys Synopsys Inc, Sells Xylem Inc, Illumina Inc, Ansys Inc

    GuruFocus Article or News written by insider and the topic is about:

  • RiverPark Funds: “Illumina (ILMN) has Two Large Growth Opportunities Ahead”
    insidermonkey.com

    RiverPark Funds: “Illumina (ILMN) has Two Large Growth Opportunities Ahead”

    RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.

  • Were Hedge Funds Right About Global Payments Inc (GPN)?
    insidermonkey.com

    Were Hedge Funds Right About Global Payments Inc (GPN)?

    Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a…

  • Were Hedge Funds Right About Twilio Inc. (TWLO)?
    insidermonkey.com

  • U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.41% By Investing.com
    investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.41% By Investing.com

    U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.41%

  • Tesla And eBay Fall As The QQQ Closes Lower
    benzinga.com

    Tesla And eBay Fall As The QQQ Closes Lower

    U.S. indices had a mixed day of trading Friday following better-than-expected jobs data. The unemployment rate for July came in at 5.4%, which was …

  • Looking for a Growth Stock? 3 Reasons Why Illumina (ILMN) is a Solid Choice
    zacks.com

    Looking for a Growth Stock? 3 Reasons Why Illumina (ILMN) is a Solid Choice

    Illumina (ILMN) possesses solid growth attributes, which could help it handily outperform the market.

  • Cancer Diagnostics Market Size Worth USD 163,000 Million by 2025 at 8.9% CAGR - Report by Market Research Future (MRFR)
    globenewswire.com

    Cancer Diagnostics Market Size Worth USD 163,000 Million by 2025 at 8.9% CAGR – Report by Market Research Future (MRFR)

    Cancer Diagnostics Market Insights and Industry Analysis by Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and others),…

  • Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up
    zacks.com

    Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up

    Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.

  • Illumina posts Q2 earnings beat, raises FY forecast (NASDAQ:ILMN)
    seekingalpha.com

    Illumina posts Q2 earnings beat, raises FY forecast (NASDAQ:ILMN)

    Illumina (ILMN) reported second-quarter results that beat Wall Street estimates and raised its financial forecast for the year.Quarterly revenue increased 79% to $1.13B, beating…

  • Illumina Earnings, Revenue Beat in Q2 By Investing.com
    investing.com

  • Is Pacific Biosciences (PACB) A Smart Long-Term Buy?
    insidermonkey.com

    Is Pacific Biosciences (PACB) A Smart Long-Term Buy?

    DEVON Equity Management, an investment management firm, published its “Global Opportunities Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.

  • HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
    globenewswire.com

    HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe

    HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology Intended to serve as one of the…

  • Earnings Scheduled For August 5, 2021
    benzinga.com

    Earnings Scheduled For August 5, 2021

    Companies Reporting Before The Bell
    • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …

  • Illumina Q2 2021 Earnings Preview (NASDAQ:ILMN)
    seekingalpha.com

    Illumina Q2 2021 Earnings Preview (NASDAQ:ILMN)

    Illumina (NASDAQ:ILMN) is scheduled to announce Q2 earnings results on Thursday, August 5th, after market close.The consensus EPS Estimate is $1.36 (+119.4% Y/Y) and the consensus…

  • Global Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026 - Increasing Demand For Personalized Medicine To Bode Well For Market...
    thestreet.com

    Global Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026 – Increasing Demand For Personalized Medicine To Bode Well For Market Growth

    DUBLIN, Aug. 4, 2021 /PRNewswire/ — The “Global Proteomics Market, By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery,

  • Facebook acquisition review shows EU’s new antitrust power
    livemint.com

    Facebook acquisition review shows EU’s new antitrust power

    EU’s Vestager in March widened scope of deal reviews, part of growing global scrutiny of takeover deals

  • 3 Things About Illumina That Smart Investors Know
    fool.com

    3 Things About Illumina That Smart Investors Know

    The company is cemented as the industry leader, but a crack is showing.

  • After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
    fool.com

    After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?

    Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.

  • Cancer Biopsy Market Size To Reach $44.51 Billion By 2027 | CAGR: 11.13%: Grand View Research, Inc.
    markets.businessinsider.com

    Cancer Biopsy Market Size To Reach $44.51 Billion By 2027 | CAGR: 11.13%: Grand View Research, Inc.

    SAN FRANCISCO, July 29, 2021/PRNewswire/ — The global cancer biopsy market size is expected to reach USD 44.51 billion by 2027, according to a ne…

  • Close Asset Management Ltd Buys ChargePoint Holdings Inc, ChargePoint Holdings Inc, Illumina Inc, Sells Starbucks Corp, Ingredion Inc, Sony...
    gurufocus.com

    Close Asset Management Ltd Buys ChargePoint Holdings Inc, ChargePoint Holdings Inc, Illumina Inc, Sells Starbucks Corp, Ingredion Inc, Sony Group Corp

    GuruFocus Article or News written by insider and the topic is about:

  • Illumina: Not All Rests With The Grail Acquisition (NASDAQ:ILMN)
    seekingalpha.com

    Illumina: Not All Rests With The Grail Acquisition (NASDAQ:ILMN)

    Illumina's fate doesn't rely solely on the Grail transaction. The company's fundamentals have been improving in recent quarters and the stock is trading below our estimated value.

  • Next Generation Sequencing Market Size Worth USD 20,347.45 Million by 2025 at 18.05% CAGR – Report by Market Research Future (MRFR)
    globenewswire.com

    Next Generation Sequencing Market Size Worth USD 20,347.45 Million by 2025 at 18.05% CAGR – Report by Market Research Future (MRFR)

    Next-Generation Sequencing Market Insights and Industry Analysis by Technology (Targeted Sequencing & Resequencing, Whole Genome Sequencing and Whole Exome…

  • Baron Asset Fund 2Q21 Commentary
    valuewalk.com

    Baron Asset Fund 2Q21 Commentary

    TransUnion (NYSE:TRU) is a consumer credit bureau that businesses rely on to make credit and marketing decisions. Its shares increased

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Illumina Aktie

Das Unternehmen Illumina, Inc aus USA beschäftigt 8.750 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Wissenschaftliche & technische Geräte, Medizinische Geräte, Biotechnologie tätig.

Das Unternehmen Illumina, Inc ist in mehr als 73 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology  UCITS  ETF gewichtet Illumina mit 5,92% im ETF.

Entdecke die 6 ETFs in denen Illumina, Inc am höchsten gewichtet ist Insgesamt in 73 ETFs enthalten

Dir gefallen die Informationen zu Illumina?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Illumina?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Illumina?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Illumina?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba